C. Medawar

发表

Paroxetine, Panorama and user reporting of ADRs: Consumer intelligence matters in clinical practice and post-marketing drug surveillance

Andrew Herxheimer, A. Herxheimer, C. Medawar, 2002 .

The social audit: A political view

C. Medawar, 1976 .

The Antidepressant WebMarketing depression and making medicines work.

C. Medawar, Charles Medawar, 1997, The International journal of risk & safety in medicine.

Power And Dependence

C. Medawar, 1993 .

On our side of the fence

C. Medawar, 1989 .

Drug information

C. Medawar, 1993, The Lancet.

Insult or injury?: An enquiry into the marketing and advertising of British food and drug products in the Third World

C. Medawar, 1979 .

Marketing and Competition

C. Medawar, 1978 .

A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine

A. Herxheimer, C. Medawar, 2004 .

Power and dependence: Social audit on the safety of medicines

C. Medawar, B. Guthrie, E. Rassaby, 1992 .

A. Herxheimer, C. Medawar, E. Rassaby, 2018, Reactions Weekly.

NO MORE LOMOTIL FOR INFANTS

A. Herxheimer, C. Medawar, Barbara Freese, 1981, The Lancet.

Secrecy and medicines.

C. Medawar, 1996, The International journal of risk & safety in medicine.

A cynical consultation exercise?

C. Medawar, 2008, British medical journal.

Failings of the pharmaceutical industry

C. Medawar, 1988 .

Professional Drug Information: A Consumer Perspective

C. Medawar, 1989 .

DATA SHEETS: A CONSUMER PERSPECTIVE

C. Medawar, 1988, The Lancet.

Medicines out of Control? Antidepressants and the Conspiracy of Goodwill

A. Hardon, Anita Hardon, C. Medawar, 2004 .

Through the doors of deception?

C. Medawar, 1994, Nature.